Dublin, Dec. 08, 2022 (GLOBE NEWSWIRE) — “Genome Engineering Market – Global Industry Size, Share, Trends, Opportunities and Forecasts, Segmented by Technology (CRISPR, TALEN, ZFN, Anti sense, others), by delivery method (ex vivo vs. in vivo), by application, by end-user, and by region” report added of ResearchAndMarkets.com Recruitment.
The global genome engineering market is anticipated to witness remarkable growth during the forecast period. Genome engineering is a process that allows the insertion, deletion, modification, or replacement of DNA in the genome of an organism. As a result, this technology can be used for the development of new treatments, therapies, and drugs in various therapeutic areas, especially chronic diseases.
Various academic and research institutes, biotech and pharmaceutical companies have taken note of this technology and are using it to develop new treatments. For example, Synthego Corporation introduced the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Pioneers Program in October 2017. Researchers are using this Clustered Regularly Interspaced Short Palindromic Repeats to focus on discovering treatments for cancer and other disease areas.
Increased development of new technologies
Various companies and academic research institutes are using genome engineering techniques to develop new treatments and treatments. This not only helps them improvise their position, but also improves the market positioning of various companies and helps them gain an edge over other players operating in the market. For example, Sangamo Therapeutics, Inc.’s SB-FIX, a zinc finger nuclease (ZFN)-mediated in vivo genome-editing treatment for hemophilia B, has received clinical trials from the UK Medicines and Healthcare Products Regulatory Agency (MHRA). You have received your acceptance (CTA). Similarly, the first Cas9 enzyme variation to reduce off-target effects in CRISPR genome editing was introduced by Integrated DNA Technologies, Inc. in 2017. This represents an important step towards the therapeutic application of CRISPR.
Increased funding and investment for research and development
Increasing funding and investment in research and development of new genetic engineering technologies is expected to create lucrative opportunities for genome engineering market growth in the coming years. For example, the US National Institutes of Health (NIH) announced in January 2018 that it would support genome editing research through a new program called Somatic Genome Editing. The program provides grants to researchers in Canada and the United States to conduct research related to genome editing.
Expanding application fields of genomics
Applications of genomics have increased significantly over the years in various fields such as forensics, genetic disease, drug discovery, and agriculture. The advent of next-generation sequencing has increased the application of genomics across the forensic field. Future trends in genome engineering include applications in areas such as nutritional supplements and marine engineering. Personalized nutrition and precision medicine are another areas where the demand for genome engineering is expected to increase. Numerous studies and clinical trials are being conducted in different regions of the world to identify more areas where genome engineering will be used. This creates lucrative opportunities for the global genome engineering market to grow in the coming years.
Reporting scope:
In this report, the global genome engineering market is segmented into following categories along with the industry trends detailed below:
Genome Engineering Market by Technology:
-
Crisper
-
Talen
-
ZFNs
-
antisense
-
others
Genome Engineering Market by Delivery Method:
Genome Engineering Market by Application:
Genome Engineering Market, By End User:
Genome Engineering Market by Region:
-
North America
-
America
-
Canada
-
Mexico
-
Europe
-
Germany
-
France
-
England
-
Spain
-
Italy
-
Asia Pacific
-
China
-
India
-
Japan
-
Korea
-
Australia
-
South America
-
Brazil
-
Argentina
-
Columbia
-
Middle East and Africa
-
South Africa
-
Saudi Arabia
-
United Arab Emirates
Main topics:
1. Product overview
2. Survey method
3. Abstract
4. Impact of COVID-19 on Global Genome Engineering Market
5. Customer feedback
6. Global Genome Engineering Market Outlook
7.North America Genome Engineering Market Outlook
8. European Genome Engineering Market Outlook
9. Asia-Pacific Genome Engineering Market Outlook
10. South America Genome Engineering Market Outlook
11. Middle East and Africa Genome Engineering Market Outlook
12. Market dynamics
13. Market Trends and Developments
14. Porter’s Five Forces Analysis
15. Pestle Analysis
16. Competitive landscape (including SWOT analysis of profiled players)
17. Strategic Recommendations
companies mentioned
-
Merck KGaA
-
Sangamo Therapeutics, Inc.
-
GenScript Biotech Corporation
-
CRISPR Therapeutics AG
-
Editas Medicine Co., Ltd.
-
Precision Bioscience Co., Ltd.
-
Horizon Discovery Group plc
-
Lonza Group Co., Ltd.
-
Origin Technologies Co., Ltd.
-
Transposagen Biopharmaceuticals, Inc.
For more information on this report, please visit https://www.researchandmarkets.com/r/xnfmiz.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
